Prevailing Antagonistic Risks in Pleiotropic Associations with Alzheimer's Disease and Diabetes.
暂无分享,去创建一个
[1] J. Hardy,et al. Diabetes and Alzheimer's disease: shared genetic susceptibility? , 2022, The Lancet Neurology.
[2] S. Gharaghani,et al. Exploring the role of non-coding RNAs as potential candidate biomarkers in the cross-talk between diabetes mellitus and Alzheimer’s disease , 2022, Frontiers in Aging Neuroscience.
[3] A. Arnaiz-Villena,et al. Evolution and molecular interactions of major histocompatibility complex (MHC)-G, -E and -F genes , 2022, Cellular and Molecular Life Sciences.
[4] K. Lunetta,et al. Midlife lipid and glucose levels are associated with Alzheimer's disease , 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.
[5] Anonymous,et al. 2022 Alzheimer's disease facts and figures , 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.
[6] Liang Shen,et al. Causal association evaluation of diabetes with Alzheimer's disease and genetic analysis of antidiabetic drugs against Alzheimer's disease , 2022, Cell & bioscience.
[7] Liang He,et al. Genome‐wide analysis identified abundant genetic modulators of contributions of the apolipoprotein E alleles to Alzheimer's disease risk , 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.
[8] A. Kulminski,et al. Definitive roles of TOMM40-APOE-APOC1 variants in the Alzheimer's risk , 2021, Neurobiology of Aging.
[9] Liang He,et al. Protective association of the ε2/ε3 heterozygote with Alzheimer's disease is strengthened by TOMM40–APOE variants in men , 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.
[10] A. Uitterlinden,et al. Assessment of Advanced Glycation End Products and Receptors and the Risk of Dementia , 2021, JAMA network open.
[11] D. Nation,et al. Role of Notch signaling in neurovascular aging and Alzheimer's disease. , 2020, Seminars in cell & developmental biology.
[12] A. Arnaiz-Villena,et al. HLA‐G: Function, polymorphisms and pathology , 2020, International journal of immunogenetics.
[13] Katherine M. Siewert,et al. Multi-trait association studies discover pleiotropic loci between Alzheimer’s disease and cardiometabolic traits , 2020, Alzheimer's Research & Therapy.
[14] A. Esmaeili,et al. Crosstalk between obesity, diabetes, and alzheimer’s disease: Introducing quercetin as an effective triple herbal medicine , 2020, Ageing Research Reviews.
[15] A. Kulminski,et al. Quantitative and qualitative role of antagonistic heterogeneity in genetics of blood lipids. , 2019, The journals of gerontology. Series A, Biological sciences and medical sciences.
[16] Piyush Gondaliya,et al. Cognitive dysfunction: A growing link between diabetes and Alzheimer's disease , 2019, Drug development research.
[17] Sterling C. Johnson,et al. Non-coding variability at the APOE locus contributes to the Alzheimer’s risk , 2019, Nature Communications.
[18] A. Yashin,et al. Pleiotropic Meta-Analysis of Age-Related Phenotypes Addressing Evolutionary Uncertainty in Their Molecular Mechanisms , 2019, Front. Genet..
[19] Nick C Fox,et al. Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing , 2019, Nature Genetics.
[20] A. Tumminia,et al. Type 2 Diabetes Mellitus and Alzheimer’s Disease: Role of Insulin Signalling and Therapeutic Implications , 2018, International journal of molecular sciences.
[21] T. Chavakis,et al. The Missed Notch to Bring Down Diabetes , 2018, Trends in Endocrinology & Metabolism.
[22] A. Kulminski,et al. Strong impact of natural-selection–free heterogeneity in genetics of age-related phenotypes , 2018, Aging.
[23] Fei-fei Yan,et al. Diabetes mellitus and Alzheimer’s disease: GSK-3β as a potential link , 2018, Behavioural Brain Research.
[24] M. Fornage,et al. The Alzheimer's Disease Sequencing Project: Study design and sample selection , 2017, Neurology: Genetics.
[25] H. Deng,et al. Linking Alzheimer's disease and type 2 diabetes: Novel shared susceptibility genes detected by cFDR approach , 2017, Journal of the Neurological Sciences.
[26] M. Carrillo,et al. Sex biology contributions to vulnerability to Alzheimer's disease: A think tank convened by the Women's Alzheimer's Research Initiative , 2016, Alzheimer's & Dementia.
[27] Alan M. Kwong,et al. Next-generation genotype imputation service and methods , 2016, Nature Genetics.
[28] F. Schmitt,et al. Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology , 2016, Alzheimer's & Dementia.
[29] Liang Shen,et al. Shared Genetic Etiology between Type 2 Diabetes and Alzheimer's Disease Identified by Bioinformatics Analysis. , 2015, Journal of Alzheimer's disease : JAD.
[30] K. Hao,et al. Shared genetic etiology underlying Alzheimer's disease and type 2 diabetes. , 2015, Molecular aspects of medicine.
[31] P. Elliott,et al. UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.
[32] Xiaofeng Zhu,et al. Meta-analysis of correlated traits via summary statistics from GWASs with an application in hypertension. , 2015, American journal of human genetics.
[33] Michael W. Lutz,et al. The cis-regulatory effect of an Alzheimer’s disease-associated poly-T locus on expression of TOMM40 and apolipoprotein E genes , 2014, Alzheimer's & Dementia.
[34] M. Goddard,et al. A Multi-Trait, Meta-analysis for Detecting Pleiotropic Polymorphisms for Stature, Fatness and Reproduction in Beef Cattle , 2014, PLoS genetics.
[35] S. Craft,et al. Insulin, cognition, and dementia. , 2013, European journal of pharmacology.
[36] L. Morelli,et al. Notch signaling in the pathologic adult brain , 2013, Biomolecular concepts.
[37] L. Alberi,et al. Notch signaling in the brain: In good and bad times , 2013, Ageing Research Reviews.
[38] J. Schneider,et al. Cognition and neuropathology in aging: multidimensional perspectives from the Rush Religious Orders Study and Rush Memory And Aging Project. , 2011, Current Alzheimer research.
[39] P. Bosco,et al. APOE and Alzheimer disease: a major gene with semi-dominant inheritance , 2011, Molecular Psychiatry.
[40] J. Morris,et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[41] D. G. Clark,et al. Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease , 2011, Nature Genetics.
[42] P. Visscher,et al. GCTA: a tool for genome-wide complex trait analysis. , 2011, American journal of human genetics.
[43] S. Kanba,et al. Insulin resistance is associated with the pathology of Alzheimer disease , 2010, Neurology.
[44] Yun Li,et al. METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..
[45] L Adrienne Cupples,et al. Genetics Analysis Workshop 16 Problem 2: the Framingham Heart Study data , 2009, BMC proceedings.
[46] Thomas E. Nichols,et al. Anatomically-distinct genetic associations of APOE ɛ4 allele load with regional cortical atrophy in Alzheimer's disease , 2009, NeuroImage.
[47] L. Fratiglioni,et al. Mid- and Late-Life Diabetes in Relation to the Risk of Dementia , 2009, Diabetes.
[48] R. Mayeux,et al. Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study: implication of additional loci. , 2008, Archives of neurology.
[49] J. Wands,et al. Alzheimer's Disease is Type 3 Diabetes—Evidence Reviewed , 2008, Journal of diabetes science and technology.
[50] M. McCarthy,et al. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes , 2008, Nature Genetics.
[51] Manuel A. R. Ferreira,et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.
[52] D. Bennett,et al. Diabetes is related to cerebral infarction but not to AD pathology in older persons , 2006, Neurology.
[53] T. Arendt,et al. Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer's disease brains. , 2004, Cerebral cortex.
[54] J. Shaw,et al. Follow-up report on the diagnosis of diabetes mellitus. , 2003, Diabetes care.
[55] Xin Xu,et al. Combining dependent tests for linkage or association across multiple phenotypic traits. , 2003, Biostatistics.
[56] Matthew P. Frosch,et al. Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[57] R. Kronmal,et al. Multi-Ethnic Study of Atherosclerosis: objectives and design. , 2002, American journal of epidemiology.
[58] R. Mayeux,et al. Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. , 2001, American journal of epidemiology.
[59] P. Allison,et al. Comparing Logit and Probit Coefficients Across Groups , 1999 .
[60] A. Sharrett. The Atherosclerosis Risk in Communities (ARIC) Study. Introduction and objectives of the hemostasis component. , 1992, Annals of epidemiology.
[61] R. Kronmal,et al. The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.
[62] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[63] L. Grinberg,et al. Diabetes is Not Associated with Alzheimer's Disease Neuropathology. , 2017, Journal of Alzheimer's disease : JAD.
[64] M. Baumann,et al. Notch signaling and ageing. , 2015, Advances in experimental medicine and biology.
[65] C. Franceschi,et al. An APOE haplotype associated with decreased ε4 expression increases the risk of late onset Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.
[66] L. Kuller,et al. Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study. , 2008, Archives of neurology.
[67] A. J. Slater,et al. Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. , 2008, Archives of neurology.
[68] J. Wands,et al. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes? , 2005, Journal of Alzheimer's disease : JAD.